ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cherian, M.
Right arrow Articles by Goyer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cherian, M.
Right arrow Articles by Goyer, R.
Annals of Clinical and Laboratory Science, Vol 8, Issue 2, 91-94
Copyright © 1978 by Association of Clinical Scientists


Articles

Role of metallothioneins in disease

MG Cherian and RA Goyer

Metallothioneins are small proteins (6,000 to 10,000 mw) with similar amino acid compositions, high content of sulfhydryl amino acids and no aromatic amino acids. Emax at 250 nm is due to cadmium mercaptide bond. Synthesis is induced by a number of metals including zinc, cadmium, mercury, copper, bismuth, gold and silver. These proteins function as a mechanism of intracellular storage of some essential metals such as zinc and copper. Binding of potentially toxic metals like cadmium may be protective; but with saturation of protein by metal, toxicity may occur. Excessive cadmium-thionein may have a role in the pathogenesis of cadmium induced kidney disease. A more sensitive method for detection adn measurement of this protein will greatly enhance future studies, particularly the potential for clinical application.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the Association of Clinical Scientists.